ImmunityBio Announces Approval in Macau SAR, China for ANKTIVA® in BCG-Unresponsive NMIBC with CIS ± Papillary Tumors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. MRK

Go back to ImmunityBio Announces Approval in Macau SAR, China for ANKTIVA® in BCG-Unresponsive NMIBC with CIS ± Papillary Tumors
(NASDAQ: IBRX) Delayed: 7.80 +0.48 (6.56%)
Previous Close $7.32    52 Week High $ 
Open $7.34    52 Week Low $ 
Day High $7.97    P/E N/A 
Day Low $7.26    EPS $ 
Volume 16,518,961